Molecular and Clinical Oncology · 2012 · 41 citations · 18 references
MedicineCell BiologyOncologyChemotherapyMolecular OncologyStem Cell BiologyBladder CancerCancer Stem Cell BiologyCancer Stem Cell HeterogeneityCancer Stem CellsStem Cell TumorigenicityCancer Stem Cell MarkersCancer Stem Cell Surface MarkersCancer Stem Cell TraitsCancer Stem-like CellsCd133 ExpressionGenitourinary MalignancyTumor Growth Heterogeneity
Cancer stem cells (CSCs) are thought to be crucial for understanding the biological roots of cancer, and are of increasing importance as a target for new anticancer agents. According to an expression analysis of the cell surface antigens of various types of cancer, CD133 is considered to be a potential marker of cancer stemness. In this study, a human urinary bladder cancer cell line (J82) was used to analyze the cancer stem cell-like characteristics of CD133+ bladder cancer cells in vitro and in vivo. The CD133 expression in the J82 cells was examined and the cells were immunomagnetically categorized into positive and negative subsets. The CD133- and CD133+ subsets were phenotypically divergent with regard to the cell growth pattern, while CD133+ cells tended to colonize during their growth. In CD133+ cells, the pluripotent stem cell factors Oct-4 and Sox-2 were upregulated, and a statistically significant proliferation increase was observed when compared to CD133- cells. The CD133+ subpopulation was more tolerant to the chemotherapeutic agent cisplatin, and Bacillus Calmette-Guérin (BCG), an agent instilled intravesically to treat bladder cancer. In addition, CD133+ J82 cells were more resistant to radiation treatment when compared to CD133- cells. The in vivo tumorigenesis of the CD133- and CD133+ subsets of J82 cancer cells was also examined by subcutaneously injecting them into nude mice. The tumor growth was more aggressive in the CD133+ subpopulation, showing a significant difference in the tumorigenic potential in these subsets. In conclusion, J82 human bladder cancer cells include CD133- and CD133+ subpopulations, while the CD133 molecule is a potential marker of the potential malignancy of human bladder cancer. In the present study, the CD133+ subpopulation was herein demonstrated to have certain characteristics consistent with those of cancer stem cells.
18
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay, Hai‐Rim Shin, Freddie Bray et al. · International Journal of Cancer · 2010 · 21.4K citations
Identification and expansion of human colon-cancer-initiating cells
Lucia Ricci‐Vitiani, Dario Lombardi, Emanuela Pilozzi et al. · Nature · 2006 · 4K citations
Medicine, Cancer Biology, Oncology +12
Phenotypic characterization of human colorectal cancer stem cells
Piero Dalerba, Scott J. Dylla, In-Kyung Park et al. · Proceedings of the National Academy of Sciences · 2007 · 2.2K citations · Full text
Medicine, Cell Biology, Oncology +17
AC133, a Novel Marker for Human Hematopoietic Stem and Progenitor Cells
Amy H. Yin, Sheri Miraglia, Esmail D. Zanjani et al. · Blood · 1997 · 1.8K citations · Full text
A Tumorigenic Subpopulation with Stem Cell Properties in Melanomas
Dong Fang, Thiennga K. Nguyen, Kim Leishear et al. · Cancer Research · 2005 · 1.3K citations · Full text